🔗 Share this article

An underground economy for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to users injecting products of uncertain source.

Several experts said the popularity for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Content Removal

According to the social media company, the service has taken down violative material and prohibited related keywords and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of weight loss, glowing reviews and detailed guides for preparing or injecting at residence.

After moments of joining one group, a vendor posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Product Information and Costs

Inside these groups, messages display black plastic packages with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly significant medical dangers”.